BTIG Initiates Coverage of ORIC Pharmaceuticals at Buy
Published . Updated .
Fintel reports that on September 23, 2026, BTIG initiated coverage of ORIC Pharmaceuticals (NASDAQGS:ORIC) (DB:4TZ) with a Buy recommendation.ORIC Pharmaceuticals, Inc., based in the United States, operates within the biotechnology sector, primarily focusing on the development of
Directly affected
- ORIC Oric Pharmaceuticals
Named in this report.
Indirectly affected
- XPH STATE STREET SPDR S&P PHARMACEUTICALS ETF
GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Fintel reports that on September 23, 2026, BTIG initiated coverage of ORIC Pharmaceuticals (NASDAQGS:ORIC) (DB:4TZ) with a Buy recommendation.ORIC Pharmaceuticals, Inc., based in the United States, operates within the biotechnology sector,…
Source: Nasdaq Markets
State Street Spdr S&P Pharmaceuticals Etf (XPH) since this story, compared with the market
Since the first closing price after “BTIG Initiates Coverage of ORIC Pharmaceuticals at Buy,” State Street Spdr S&P Pharmaceuticals Etf (XPH) is -6.41%. The S&P 500 fund (SPY) is -0.09% over the same days, a -6.32% difference versus the market.
Who gains and who loses around State Street Spdr S&P Pharmaceuticals Etf (XPH)
Companies mentioned with this story
- XPH State Street Spdr S&P Pharmaceuticals Etf
For “BTIG Initiates Coverage of ORIC Pharmaceuticals at Buy,” State Street Spdr S&P Pharmaceuticals Etf (XPH) is linked, with no stored direction, medium confidence. Reason on file: GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ORIC Oric Pharmaceuticals
In “BTIG Initiates Coverage of ORIC Pharmaceuticals at Buy,” Oric Pharmaceuticals (ORIC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ORIC as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals, oric. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “BTIG Initiates Coverage of ORIC Pharmaceuticals at Buy” reaches State Street Spdr S&P Pharmaceuticals Etf (XPH)
On 23 Sep 2026, “BTIG Initiates Coverage of ORIC Pharmaceuticals at Buy” is the story that connects State Street Spdr S&P Pharmaceuticals Etf (XPH) to this story.
For State Street Spdr S&P Pharmaceuticals Etf (XPH), the reason on file says GA selected XPH as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Also listed, Oric Pharmaceuticals (ORIC): GA selected ORIC as a RELATED security because its canonical security name directly matches this event's themes: pharmaceuticals, oric. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Price levels for State Street Spdr S&P Pharmaceuticals Etf (XPH)
ORIC traded between 10.92 and 14.08 across 19 sessions. The latest close on file is 12.74. XPH traded between 61.54 and 68.95 across 20 sessions. The latest close on file is 62.24.
A simple score for State Street Spdr S&P Pharmaceuticals Etf (XPH)
21 out of 100
“BTIG Initiates Coverage of ORIC Pharmaceuticals at Buy” scores 21 out of 100. The score uses 1 sources, and 2 linked companies.